Effect of the compound "chloridarol" on plasma lipids and apolipoprotein levels.
Eighteen subjects, nine affected with type IIB and nine with type IV hyperlipemia, following since months a "prudent diet" received 750 mg/day of the compound/(2-benzofuryl) (p-chlorophenyl) carbinol/ for two 2-month periods. The results obtained were compared with those obtained following only dietary treatment. The pharmacological treatment significantly reduced the plasma levels of triglycerides and apoB.
D001053:Apolipoproteins / Q000097:blood*; D001055:Apolipoproteins B; D001572:Benzofurans / Q000494:pharmacology*; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D001053:Apolipoproteins; D001055:Apolipoproteins B; D001572:Benzofurans; D000960:Hypolipidemic Agents; D008055:Lipids; D014280:Triglycerides; C002971:cloridarol